Drug affordability principles
Americans need affordable access to drugs and biologics, which requires a multi-faceted approach from across the health care system.
AGA position: Drug affordability should be focused on decreasing out-of-pocket expenses for patients, maintaining reasonable incentives for innovation, increasing cost transparency, promoting shared decision-making and boosting competition.
Americans with digestive diseases need affordable access to drugs and biologics. Increasing out-of-pocket expenses limit patient access. Improving affordability requires a multi-faceted approach from across the health care system, including health insurers, drug and biologic manufacturers, and pharmacy benefit managers. As these stakeholders and policymakers work to improve the affordability of drugs and biologics in the U.S., AGA urges focus on five key principles:
Prior authorization delays care.
